Home » Topics » Regulatory

Regulatory
RSS

Topical interferon alfa enters phase II for intravaginal warts

Feb. 2, 1998

Controlled-release oxybutynin to be marketed in Europe by Synthelabo

Feb. 2, 1998

Suramin submitted for FDA approval for cancer indication

Jan. 30, 1998

Proleukin cleared for marketing in U.S. for melanoma indication

Jan. 30, 1998

Anesta signs European marketing agreement for Actiq

Jan. 29, 1998

New once-daily rosacea therapy introduced in U.S.

Jan. 27, 1998

Once-daily hair loss treatment available throughout the U.S.

Jan. 27, 1998

Botox compared to saline for chronic anal fissure

Jan. 22, 1998

Timentin cleared for pediatric use in U.S.

Jan. 22, 1998

Pfizer to develop Nastech formulation of sleep aid

Jan. 21, 1998